| Withdrawn | Comparison of Captisol-Enabled™ Iohexol and Omnipaque™ in Patients With Impaired Renal Function Undergoing Cor Contrast-induced Nephropathy | Phase 2 | 2022-01-01 |
| Completed | A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 2 | 2016-09-01 |
| Completed | A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation Type 2 Diabetes Mellitus (T2DM) | Phase 1 | 2016-02-01 |
| Completed | Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 1 | 2014-10-01 |
| Completed | Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects Type 2 Diabetes Mellitus | Phase 1 | 2013-11-01 |
| Withdrawn | Study of MB07811 in Subjects With Hypercholesterolemia Hypercholesterolemia | Phase 2 | 2009-04-01 |
| Completed | A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension Hypertension | Phase 2 | 2008-03-01 |
| Completed | The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs Syndrome Restless Legs Syndrome | Phase 2 | 2008-02-01 |
| Completed | Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Enviro Seasonal Allergic Rhinitis | Phase 2 | 2008-02-01 |
| Completed | The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease Early Stage Parkinson's Disease | Phase 2 | 2008-01-01 |
| Completed | A Trial to Evaluate the Safety and Efficacy of PS433540 to Treat Hypertension Hypertension | Phase 2 | 2007-08-01 |
| Completed | Safety, Tolerability, and Efficacy Study of MB07803 Administered to Patients With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 2 | 2007-03-01 |
| Completed | Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR Seasonal Allergic Rhinitis | Phase 2 | 2007-02-01 |
| Completed | The Prevention Of Postmenopausal Osteoporosis With Lasofoxifene And Cytokine Evaluation Bone Loss | Phase 2 | 2004-09-01 |
| Completed | Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation Osteoporosis | Phase 2 | 2004-06-01 |
| Completed | Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2003-09-01 |
| Completed | Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Los Osteoporosis | Phase 3 | 2003-05-01 |
| Completed | Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL) Osteoporosis | Phase 3 | 2001-11-01 |
| Completed | Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphom Drug/Agent Toxicity by Tissue/Organ, Lymphoma | Phase 2 | 1999-11-01 |
| Completed | Bexarotene in Treating Patients With Metastatic Breast Cancer Breast Cancer | Phase 2 | 1998-10-01 |
| Completed | A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma Sarcoma, Kaposi, HIV Infections | Phase 2 | — |